The Neurosurgical Treatment of Alzheimer's Disease: A Review

Abstract

Background: Alzheimer's disease (AD) is a debilitating neurological illness of increasing prevalence. Because many patients are affected and current treatments have limited effectiveness, other therapeutic strategies are urgently needed. Objectives: Here we provide a review of the neurosurgical approaches that have been attempted or are currently being investigated for the treatment of AD. Methods: Computerized database searches identified all of the published studies in the English-language literature examining the surgical treatment of AD since 1950. Results: The following 5 categories of neurosurgical treatment were identified: cerebrospinal fluid shunting, intraventricular infusions, tissue grafting, gene therapy, and electrical neural stimulation. Conclusions: While none of the neurosurgical approaches applied to the treatment of AD have proven effective to date, recent trials involving gene therapy and electrical neural stimulation are showing promising early results. Larger trials investigating these treatments have been proposed or are currently under way.

Trigeminal, Visceral and Vestibular Inputs May Improve Cognitive Functions by Acting through the Locus Coeruleus and the Ascending Reticular Activating System: A New Hypothesis

“…Another interesting field of application for peripheral activation of signals with a high impact on ARAS structures could be that of neurodegenerative disease. A recent approach to the treatment of AD has been to modulate brain activity through electrical stimulation of peripheral nerve and deep brain structures (see Laxton et al, 2014 , for reference). As recently proposed, when neurons die synaptic activity on target cells is reduced, leading to upregulation of AMPA receptors, in an attempt to stabilize the global activity of the circuit (Palop and Mucke, 2010 ) and, as a consequence, to an increased cell excitability (Fröhlich et al, 2008 ).…”

Targeted Nanoparticles for the Treatment of Alzheimer's Disease

“…By using invasive methods of administration like the temporal disruption of the BBB integrity [99], intracerebroventricular infusion [100] or intracerebral implants, the drug can be administered directly into the brain tissue, overcoming the BBB. Nevertheless these methods are not convenient for use in humans for several reasons, including safety and costs [101,102].…”

The rationale for deep brain stimulation in Alzheimer’s disease

“…Consequently, there has been growing interest in modulating the activity of these dysfunctional circuits in order to maximize their function (Laxton et al 2010(Laxton et al , 2014Laxton and Lozano 2013;Sharma et al 2015).…”